Project Name：Tofa erlotinib 

Registration Classification：3.1

Formulations and specifications ：Tablets: 5mg 

Indications：Methotrexate is used to treat inadequate response or intolerance of moderate to severe active rheumatoid arthritis (RA) treatment of adult patients .

Original Research ：Pfizer 

Progress ：Pharmaceutical Research in progress